Company intelligence / Profile preview

Bio2 Technologies

Woburn, Massachusetts, United Statesbio2tech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bio2 Technologies has developed a proprietary resorbable biomaterial platform for orthopedic implants. Their first product line received FDA clearance in December 2014. Preclinical studies have shown excellent bioactivity and mechanical strength, with ongoing expansion into spine and extremities markets. The company’s technology enables faster tissue ingrowth due to its biomimetic structure, with broad potential applications across musculoskeletal surgeries.

Therapeutic areas: OtherNeurology
Modalities: DeviceBiomaterial-based implantResorbable implant
Industry: Implantable Medical Devices

Partnerships

None publicly disclosed; strategic partnerships are part of the business model but not named specifically

Beyond the preview

Go deeper on Bio2 Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio2 Technologies.